Aerska

Bioscience & Disease Healthcare Systems Deep Tech

Bioscience & Disease Healthcare Systems +1

@AerskaBiotech Website LinkedIn Dublin, Ireland

About Aerska

Aerska is a biotechnology startup pioneering the development of systemically administered RNA interference (RNAi) medicines aimed at treating, delaying, and preventing diseases of the brain. The company focuses on overcoming the challenges of delivering genetic medicines across the blood-brain barrier.

Business Information

Target Customers

pharmaceutical companies research institutions healthcare providers

Industry Categories

Bioscience & Disease Healthcare Systems Deep Tech

Business Model

Revenue Model Partnerships and licensing

Pricing Strategy N/A

Sales Channels direct sales, partnerships

Funding Timeline

Round	Date	Amount	Investors
Seed	Nov 04, 2025	$21.0M	@age1vc, @BackedVC, Speedinvest

Founders

Jack O’Meara

Co-Founder & CEO

Investors

@BackedVC

Venture Capital

@age1vc

Venture Capital

Speedinvest

Venture Capital

Recent Mentions

Entrepreneurs First @join_ef

Nov 04, 2025

3/ Aerska (Jack O’Meara CEO) raises $21M in Seed round Aerska has raised $21M in Seed funding, with the latest round co-led by @age1vc, @BackedVC and @speedinvest. Founded in 2025, the Dublin-based biotech startup is developing systemically administered RNA interference (RNAi) https://t.co/SSDxwNeCxt

View on Twitter

Similar Startups

Aureka Biotechnologies

87% match

Aureka Biotechnologies focuses on AI-driven antibody design, committed to democratizing the pharmace...

AeroRx Therapeutics

86% match

AeroRx Therapeutics is a clinical-stage biopharmaceutical startup focused on developing proprietary,...

Affinia Therapeutics

86% match

Affinia Therapeutics is an innovative biotechnology company pioneering adeno-associated virus (AAV) ...

AAVantgarde Bio

86% match

AAVantgarde Bio is a clinical-stage biotechnology company developing next-generation gene therapies ...